Welcome to BioMarket Group!

Deals and alliances in oncology

Additional Information

Published Date Apr 1, 2006
Special Offer No
Pages 1934
PDF Fact Sheet View Fact Sheet for the report Deals and alliances in oncology in PDF format.
Published on Date No
Format No
Publisher N/A
Product Line No
Full Title No

Availability: In stock

$2,495.00

Quick Overview

Identify the latest dealmaking trends in your field
Request free sample pages from Deals and alliances in oncology

Partneringdesk deals and alliances in oncology diseases provides an in-depth view of deals and alliances announced in oncology diseases between 2001 and 2006, in a clear and accessible PDF format.


Introduction

A diagrammatical and analytical summary of the deals and dealmakers in the therapy area over a five-year period.


Chapter 1: Deals by company

A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.


Chapter 2: Deals by development stage

A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.


Chapter 3: Deal type

Access deal information by type of transaction – see who is licensing or partnering and using what type of deal.


Chapter 4: Industry sector

Deal announcements sorted by industry sector. Choose from nine sectors.


Chapter 5: Top 25 company profiles

Summary profiles for the most active companies in the therapy area over the past five years, including contact details, business strategy, partnering strategy, R&D and history.


Chapter 6: Detailed listing of deals and alliances

A full index of all the deals announced between Jan 2001 and Mar 2006.


Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments.Every deal entry includes a detailed deal description and financial information where disclosed, such as headline values, upfront and milestone payments, and links to the full deal in the deal listing at the rear of each report.

Request free sample pages from Deals and alliances in oncology

Other selected research from the 'Business Development' category:


Biotech and Pharmaceutical Spinouts: Maximize your assets potential in a context of increasing earning pressures
Biotechnology and pharmaceutical companies are increasing their focus on their intellectual property and assets management. Portfolio management and business development teams are becoming aware of the potential to capitalize on their company`s non-core assets and to access niche markets by spinning out new, independent biotechnology companies backed by important venture capital investments. Learn More


Clinical Trials: World Market 2010-2025
trends for outsourcing and off-shoring of clinical testing
The market for clinical trial services has been expanding rapidly, with impressive revenue growth and expansion of the sector in recent...
Learn More

Other selected research from the 'Oncology' category:


Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Antibodies
This triple analysis focuses on cancer drug development strategies in both Colorectal Cancer and Pancreatic Cancer and by the compound strategy of Antibodies. Learn More


Lymphoma - A Therapeutic & Competitive Insight
Gain insight into the current challenges and commercial opportunities associated with lymphoma therapy Learn More